Browse the evidence

Prescription omega-3 fatty acids (EPA+DHA or EPA-only) at a dose of 4 g/d reduce triglycerides by 30-35% in patients with very high triglycerides (≥500 mg/dL) and by approximately 27% in those with high triglycerides (200-499 mg/dL).

If you have high triglycerides, ask your doctor about prescription omega-3s (like Vascepa or Lovaza) taken at 4 grams per day. These are different from store-bought supplements because they are held to stricter FDA standards. They can lower your triglycerides by about 30%, but you should also focus on lifestyle changes like losing weight, limiting alcohol, and managing blood sugar.

Aerobic exercise consistently increases HDL-C levels (including protective HDL2-C subfractions) and reduces triglycerides, serving as a viable non-pharmacological intervention for dyslipidemia.

Commit to aerobic exercise at least 3 times a week for 30-45 minutes. You do not need to lose weight for this to improve your HDL (good cholesterol). Moderate intensity is sufficient for most people, though higher intensity may be needed for specific triglyceride goals in some cases.

Supplementation with 20 g/day of inulin-propionate ester (IPE) or inulin for 42 days improves insulin sensitivity in adults with overweight and obesity compared to cellulose.

If you have overweight or obesity, adding 20 grams daily of either inulin or inulin-propionate ester (IPE) to your diet for about six weeks can improve how your body handles insulin compared to eating non-fermentable fiber. You can split the dose into two 10-gram servings mixed into your food. While both work similarly for insulin sensitivity, IPE specifically reduces inflammatory markers, whereas inulin changes gut bacteria differently. Consult your doctor before starting, especially if you have existing digestive conditions.

GLP-1 receptor agonists (GLP-1RAs) such as liraglutide and exenatide effectively treat Type 2 Diabetes by enhancing insulin secretion and inducing weight loss, serving as a pharmacological alternative to bariatric surgery.

If you have Type 2 Diabetes and struggle with weight, GLP-1 medications like liraglutide or exenatide are proven to help your body produce more insulin and lose weight. They are a viable alternative to bariatric surgery, offering similar benefits without the surgical risks. Consult your doctor to see if this class of medication is appropriate for you.

Modest weight loss (approximately 5%) significantly improves reproductive, hyperandrogenic, and metabolic features in women with PCOS.

For women with PCOS, losing just 5% of body weight can significantly improve hormonal balance, metabolic health, and fertility. Focus on sustainable lifestyle changes rather than extreme diets, as even small amounts of weight loss yield clinical benefits.

Moderate exercise (30-60 minutes per day) improves menstrual cyclicity and ovulation rates in women with PCOS, whereas excessive exercise (>60 minutes) increases the risk of anovulation.

Aim for 30-60 minutes of moderate aerobic exercise daily. This duration improves ovulation and menstrual regularity in about half of women with PCOS. Avoid exercising for more than 60 minutes a day, as this may disrupt ovulation.

Dual GIP/GLP-1 receptor agonism (e.g., tirzepatide) produces superior glycemic control and body weight loss compared to selective GLP-1 receptor agonists (e.g., dulaglutide) in type 2 diabetes, likely by enhancing WAT lipid buffering and CNS-mediated appetite suppression.

For individuals with Type 2 Diabetes, dual-acting incretin medications (like tirzepatide) that target both GIP and GLP-1 receptors have shown superior results in lowering blood sugar and reducing body weight compared to older GLP-1-only medications. This is achieved through once-weekly dosing. The mechanism involves not just appetite suppression in the brain, but also improved fat storage capacity in white adipose tissue, which helps manage blood lipids. While gastrointestinal side effects like nausea are common, the dual mechanism may actually help mitigate some of these side effects compared to high-dose GLP-1 monotherapy, allowing for better long-term adherence and efficacy.

A ketogenic diet (KD) improves glycemic control and insulin sensitivity in patients with Type 2 Diabetes Mellitus (T2DM) by reducing carbohydrate intake, lowering serum insulin, and enhancing fat catabolism.

For T2DM patients, adopting a ketogenic diet can significantly lower blood sugar and HbA1c levels compared to standard low-calorie diets. This is achieved by restricting carbohydrates, which lowers insulin levels and improves insulin sensitivity. However, medical supervision is critical, especially if you are taking insulin or SGLT2 inhibitors, to avoid dangerous side effects like hypoglycemia or ketoacidosis.

Switching patients from DPP-4 inhibitors to GLP-1 receptor agonists improves glycemic control and weight loss, although it may transiently increase gastrointestinal adverse events.

If you are taking a DPP-4 inhibitor (like sitagliptin) and your blood sugar or weight goals aren't being met, switching to a GLP-1 receptor agonist (like exenatide or liraglutide) is a recommended next step. This switch typically leads to better blood sugar control and more weight loss. You may experience some temporary stomach issues, but these often subside.

Weight loss and lifestyle modifications (diet, exercise, sleep) are the most effective management strategies for PCOS, as they improve insulin sensitivity, reduce hyperandrogenism, and restore reproductive function.

Focus on sustainable lifestyle changes rather than quick fixes. Aim for a modest 5% weight loss if overweight, as this significantly improves PCOS symptoms. Engage in 30-60 minutes of moderate physical activity daily; avoid excessive exercise which may worsen anovulation. Prioritize sleep sufficiency (7-8 hours) as it is a prerequisite for successful weight loss and metabolic health.

Insufficient sleep duration (less than 7 hours) disrupts hormonal regulation of appetite by decreasing leptin and increasing ghrelin, leading to increased caloric intake, preference for high-calorie foods, and higher risk of obesity.

Prioritize getting 7-9 hours of sleep. If you are sleep-deprived, you are biologically predisposed to eat more and crave high-calorie foods due to hormonal shifts (low leptin, high ghrelin). Fixing sleep is often more effective for weight management than dieting alone.

Consumption of whole grains, particularly those rich in soluble fiber like beta-glucan and arabinoxylan, reduces the risk of cardiovascular disease and type 2 diabetes by lowering blood cholesterol and post-prandial glucose levels.

Replace refined grain products (white bread, white rice, regular pasta) with whole grain versions (whole wheat bread, brown rice, whole grain pasta) to increase your intake of soluble and insoluble fiber. This helps manage cholesterol and blood sugar levels, reducing the risk of heart disease and type 2 diabetes. Aim for at least 2.5 servings (approx. 50g) of whole grains per day, as recommended by many national guidelines.

Physical activity, particularly aerobic and resistance exercise, improves cognitive processes, memory, and brain health by increasing circulating neurotrophins (BDNF, IGF-1) and myokines that cross the blood-brain barrier to promote neuroplasticity and neurogenesis.

Engage in regular physical activity, combining aerobic and resistance exercises, to support brain health. You do not need extreme intensity; even walking while learning can boost memory. The key is consistency and moving more throughout the day to release beneficial factors like BDNF that support your brain.

Obesity significantly increases the susceptibility to type 2 diabetes, with risk increasing exponentially with higher BMI levels.

If you are overweight, your risk of developing type 2 diabetes is exponentially higher than if you were at a healthy weight. This risk is not linear; higher BMI levels correspond to dramatically higher susceptibility. Weight management is the most effective way to mitigate this specific risk.

African American women with obesity and low insulin sensitivity lose significantly more fat mass and maintain higher total energy expenditure when following a low-carbohydrate diet compared to a low-fat diet.

If you are an African American woman with obesity and have struggled to lose weight on standard low-fat diets, switching to a low-carbohydrate approach (around 20% carbs, 55% fat) may help you lose more fat and keep your metabolism higher. This benefit is specifically linked to having lower insulin sensitivity, which is common in this demographic. Focus on whole foods, complex carbohydrates, and healthy fats while maintaining a caloric deficit.

Interrupting prolonged sitting with physical activity breaks significantly reduces post-prandial blood glucose, insulin, and triacylglycerol levels compared to continuous sitting.

If you sit for long periods, don't just stand up. Get up and move with light physical activity (like walking or cycling) for short breaks throughout the day. This actively lowers your blood sugar and insulin levels after eating, which is better for metabolic health than just sitting or standing still.

GLP-1 receptor agonists (specifically liraglutide) induce significant weight loss and improve metabolic parameters (insulin sensitivity, testosterone) in obese women with PCOS, offering a therapeutic avenue for infertility associated with this condition.

For women with PCOS and obesity, GLP-1 receptor agonists like liraglutide (1.2-3.0 mg daily) are a clinically supported pharmacological option to induce weight loss and reduce testosterone levels when lifestyle changes alone have failed or are difficult to maintain. This intervention targets the underlying hormonal and metabolic drivers of infertility.

Administration of specific probiotic strains (e.g., Lactobacillus gasseri BNR17, L. acidophilus La5, Bifidobacterium lactis Bb12) and prebiotics (e.g., inulin-type fructans) reduces abdominal visceral fat, body weight, and fasting plasma glucose in overweight or obese individuals.

If you are overweight with visceral fat, adding specific probiotic strains (like L. gasseri or B. lactis) or prebiotics (like inulin) to your daily diet for at least 12 weeks can help reduce belly fat and improve blood sugar control. This works best when combined with a healthy diet, as the bacteria help regulate satiety hormones.

Adiponectin levels are negatively correlated with obesity, type 2 diabetes, and cardiovascular disease, and healthy nutrition (specifically unsaturated fats and omega-3) significantly increases adiponectin levels.

Focus on a healthy diet rich in unsaturated fats and omega-3 fatty acids (like fish oil) to boost your body's natural adiponectin levels. Higher adiponectin is linked to better insulin sensitivity, lower inflammation, and reduced risk of heart disease and diabetes. This is achieved through whole foods like fruits, vegetables, whole grains, and fish, rather than processed foods high in saturated fats.

Increased skeletal muscle mass (SMI) significantly reduces the risk of developing metabolic syndrome (Met-S), while decreased muscle mass increases the risk.

Focus on maintaining or increasing your skeletal muscle mass through regular physical activity. Even a modest 1% annual increase in muscle mass can significantly lower your risk of developing metabolic syndrome. You do not need to become a bodybuilder; consistent activity that preserves muscle is metabolically protective.

Unimolecular GLP-1/GIP co-agonists (e.g., tirzepatide) produce superior weight loss and glycemic control compared to GLP-1 receptor agonists alone in patients with type 2 diabetes and obesity.

If you have type 2 diabetes or obesity, current GLP-1 medications (like semaglutide) are effective but not the most powerful option available. Newer 'co-agonist' drugs (like tirzepatide) that target both GLP-1 and GIP receptors have shown greater weight loss and better blood sugar control in clinical trials. While these are injections, they are given once a week. The main trade-off is potential gastrointestinal side effects like nausea, though these may be less severe than with some GLP-1-only drugs. Consult your doctor to see if this advanced therapy is appropriate for your specific health profile.

A 12-week intensive lifestyle intervention combining whey protein supplementation (30 g/day) and personalized resistance training significantly improves muscle mass and reduces proinflammatory cytokines (TWEAK, TNF-α, IL-18) while restoring metabolic hormone levels (adiponectin, insulin) in sarcopenic elderly patients.

For sarcopenic elderly individuals, a 12-week program combining 30g of whey protein daily (split around workouts) with 3 days of resistance training can significantly boost muscle mass and reduce harmful inflammation. The key is consistency and ensuring adequate protein intake (1.5g/kg/day) alongside strength exercises. This approach not only builds muscle but also improves the underlying hormonal and inflammatory drivers of muscle loss.

HMB supplementation enhances skeletal muscle mass, strength, and hypertrophy when combined with resistance or strenuous exercise, particularly in untrained individuals and the elderly.

If you are new to exercise or older, taking 3g of HMB daily alongside your resistance training may help you build muscle and strength faster than training alone. If you are already an elite strength athlete, you likely won't see much benefit from HMB alone. Do not expect muscle growth from HMB if you are sedentary.

Tirzepatide, a dual GIP/GLP-1 receptor agonist, produces dose-dependent reductions in HbA1c (up to 2.4%) and body weight (up to 11.3 kg) in patients with Type 2 Diabetes, with efficacy superior to the GLP-1 receptor agonist dulaglutide.

If you have Type 2 Diabetes, Tirzepatide is a once-weekly injection that significantly lowers blood sugar (HbA1c) and promotes substantial weight loss, outperforming existing GLP-1 drugs like dulaglutide in clinical trials. It works by mimicking two gut hormones (GIP and GLP-1) to improve insulin response and reduce appetite. While gastrointestinal side effects like nausea are common, they are usually mild and can be managed by starting with a low dose and increasing gradually. This treatment is suitable for adults with T2DM, including those already taking metformin.